Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

PURPOSE: Response evaluation in patients with glioblastoma after chemoradiotherapy is challenging due to progressive, contrast-enhancing lesions on MRI that do not reflect true tumour progression. In this study, we prospectively evaluated the ability of the PET tracer (18)F-fluorothymidine (FLT), a...

詳細記述

保存先:
書誌詳細
出版年:Eur J Nucl Med Mol Imaging
主要な著者: Brahm, Cyrillo G., den Hollander, Martha W., Enting, Roelien H., de Groot, Jan Cees, Solouki, A. Millad, den Dunnen, Wilfred F. A., Heesters, Mart A. A. M., Wagemakers, Michiel, Verheul, Henk M. W., de Vries, Elisabeth G. E., Pruim, Jan, Walenkamp, Annemiek M. E.
フォーマット: Artigo
言語:Inglês
出版事項: Springer Berlin Heidelberg 2018
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208814/
https://ncbi.nlm.nih.gov/pubmed/30032322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4090-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料